scholarly journals Study on the Changes of Immune Factors in Different Stages of Non-Small Cell Lung Cancer Chemotherapy

2021 ◽  
Vol 10 (04) ◽  
pp. 57-64
Author(s):  
Jingjing Zhang ◽  
Dianbin Song ◽  
Yi Dong ◽  
Lu Bai ◽  
Dongqi Gao ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Immune Factors

Unresectable Non-Small Cell Lung Cancer Chemotherapy with High-Dose Cisplatin and Etoposide

Oncology ◽  
1985 ◽  
Vol 42 (4) ◽  
pp. 224-228 ◽  
Author(s):  
Giorgio V. Scagliotti ◽  
Donatella Lodico ◽  
Felice Gozzelino ◽  
Franco Bardessono ◽  
Carlo Albera ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
High Dose ◽  
Small Cell Lung

scholarly journals PCN7 MAJOR DETERMINANTS OF COST IN ADVANCED NON-SMALL-CELL LUNG CANCER CHEMOTHERAPY REGIMES IN FRANCE

2002 ◽  
Vol 5 (6) ◽  
pp. 538-539
Author(s):  
D Tilden ◽  
M Aristides ◽  
A Kielhorn ◽  
S Bhalla
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Docetaxel and Cisplatin Regimen for Non-Small-Cell Lung Cancer

2013 ◽  
Vol 48 (7) ◽  
pp. 550-557 ◽  
Author(s):  
Jessie Yang ◽  
Dominic A. Solimando ◽  
J. Aubrey Waddell
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Malignant Diseases ◽  
Small Cell Lung ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Sign in / Sign up

Export Citation Format

Share Document